Cardiology Journal Articles

 
 
  • The Evil of the Patent Foramen Ovale: The Tip of the Iceberg A patent foramen ovale can be the cause devastating thromboembolic events. Are we underestimating the frequency of PFO-mediated events--and under-treating PFOs?
  • Mapping Repetitive Activation in Atrial Fibrillation A new study adds to our understanding of AF from a mechanistic standpoint, but questions remain as to whether the repeating pattern identified is an active driver of AF or simply passive repetition.
  • Grey Zone Fractional Flow Reserve Values: Stop or Go? What--if anything--should be done when the fractional flow reserve falls into the "grey zone"?
  • Aortic Stenosis: Then and Now Renowned cardiologist Dr. Eugene Braunwald, M.D., highlights the major developments in the assessment and management of severe aortic stenosis during the past half-century
  • Diet and Nutrition After the PURE Study Data from the Prospective Urban Rural Epidemiology (PURE) study has challenged the conventional guidance relating to fat consumption.
  • Potassium: An Ion With Dangerous Airs and Graces A new study demonstrates that both hyperkalaemia and hypokalaemia are associated with increased risk of mortality, underscoring the narrow range of a healthy serum potassium concentration.
  • In Memoriam: ARTHUR J. MOSS MD This tribute to the legacy of Dr. Arthur J. Moss, MD, highlights his pioneering work on sudden cardiac death and long-QT syndrome.
  • Epidemiology of Atrial Fibrillation What do we currently know about AF epidemiology--and where are there still knowledge gaps? This brief article summarizes recent advances and future challenges in our understanding of AF.
  • Fitness, Exercise, and Coronary Calcification Two new studies strongly confirm that physical activity reduces cardiovascular disease risk--and that CAC is a powerful predictor both of cardiovascular events and total mortality.
  • Ten Commandments of the EHRA Guide for Use of NOACs in AF Review the 10 most important take-aways from the 2018 EHRA NOAC Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with AF.
  • Ethics and the Cardiac Pacemaker When should pacemakers be deactivated, and by whom? What about conflicts of interest, security, and privacy? This commentary addresses these and other ethical issues posed by the use of these devices.
  • Heart Failure in Diabetic Patients Patients with T2DM are at increased risk of developing heart failure. This report discusses several new directions in advanced imaging and therapeutics which can improve treatment for these patients.
  • Transformative Power of Understanding and Trust in AF Care How should you talk to your patients about AF? The author outlines the five things you should communicate to your patients -- and the five they don't want to hear.
  • Targeting Treatment of PH Due to Left Heart Disease A new study indicates that treating PH-LHD with sildenafil is associated with worse clinical outcomes than placebo. How can this be explained?
  • Cell Therapy for Chronic Stroke How might stem cell therapy enhance recovery in recurrent stroke? This paper explores mechanisms of action, stem cell types, routes of administration, and current evidence supporting this approach.
  • Ezetimibe: Likely to Be Beneficial For All Is ezetimibe therapy equally beneficial to patients with or without diabetes mellitus? This commentary focuses on the clinical implications of the IMPROVE-IT trial.
  • Lipids and Lipid Lowering With Statins and PCSK9 Inhibitors This commentary summarizes multiple recent studies on the use of statins and PCSK9 inhibitors as well as new insights into the relationship of HDL, LDL, the immune system, and atherosclerosis.
  • Advances in Stroke 2017 This comprehensive paper summarizes the many advances in stroke medicine, stroke genetics, and other areas of stroke research that took center stage in 2017.
  • The Value of Guidelines in Everyday Clinical Practice This brief commentary explores some of the issues and challenges surrounding the use of clinical guidelines in cardiology.
  • Role of Blood Lipids in the Development of Ischemic Stroke What roles do LDL cholesterol, HDL cholesterol, and triglycerides play in the development of ischemic stroke and its 3 main subtypes?